COMMUNIQUÉS West-GlobeNewswire

Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
05/01/2018
YARDLEY, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ: ALQA ) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding lives, today [...]
Akcea Initiates Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia and Established Cardiovascular Disease
05/01/2018
CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]
Amedisys to Present at the 36th Annual J.P. Morgan Healthcare Conference
05/01/2018
BATON ROUGE, La., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive [...]
VALNEVA : Bilan semestriel du Contrat de liquidité
05/01/2018
Paris, le 5 janvier 2018 Bilan semestriel du contrat de liquidité VALNEVA contracté avec NATIXIS Au titre du contrat de liquidité confié à NATIXIS portant sur les actions de la société VALNEVA, à la date du 29 décembre [...]
VALNEVA : Déclaration d'actions et de droits de vote décembre 2017
05/01/2018
VALNEVA Déclaration d'actions et de droits de vote - DECEMBRE 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
BioCorRx Retains Regulatory Drug Expert Priya Jambhekar and CMC Expert Bruce Firestone, Ph.D
05/01/2018
ANAHEIM, CA, Jan. 05, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that it has [...]
Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference
05/01/2018
LONDON, Ontario, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp (TSX-V: SVA ) (OTCQB:SEOVF) (FSE:PSH), a clinical stage regenerative medicine company, today announced that Dr. Philip Toleikis, Sernova’s President and [...]
Skyline Medical Announces Pricing of Firm Commitment Public Offering of Common Stock and Warrants
05/01/2018
MINNEAPOLIS, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
APEIRON to Present at the Biotech Showcase™ Annual Conference on January 9, 2018
05/01/2018
VIENNA, Austria, Jan. 05, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 at the Hilton [...]
Radius Health to Present at the 36th Annual J.P. Morgan Healthcare Conference
05/01/2018
WALTHAM, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), today announced that President and Chief Executive Officer, Jesper Høiland, will present a corporate update at the 36th Annual J.P. [...]
OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017
05/01/2018
WARSAW, Ind., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary [...]
bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
05/01/2018
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect and treat multiple [...]
Novan Announces Pricing of $38.0 Million Offering of Common Stock and Warrants
05/01/2018
MORRISVILLE, N.C., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced the pricing of the Company's underwritten offering of 10 million shares of its common stock and [...]
Burcon Announces Rights Offering
05/01/2018
VANCOUVER, British Columbia, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon ") is pleased to announce that it will be offering rights (the " Rights Offering ") to [...]
Agritek Holdings Inc. CEO B. Michael Friedman Issues Letter to Shareholders
05/01/2018
LOS ANGELES, CA, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor®
05/01/2018
Anticipated Cost Savings of $7-$8 Million MORRISTOWN, N.J., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced that, due to the [...]
Bavarian Nordic A/S - Articles of Association
05/01/2018
Updated Articles of Association for Bavarian Nordic A/S Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/899513cf-91d6-4ada-a6ca-a627649f9371
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
05/01/2018
TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company working to improve patient lives by providing high quality biologics manufacturing services [...]
Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
05/01/2018
SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported [...]

Pages